News

Gen-Probe Incorporated (Gen-Probe) has announced that Prodesse’s ProParaflu+ assay has received US Food & Drug (FDA) approval. This assay is a molecular test that detects and differentiates parainfluenza

Æterna Zentaris has announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial

Simulations Plus has released GastroPlus Version 6.1, the latest version of its software used by pharmaceutical research scientists for simulation of oral absorption, intravenous dosing, pharmacokinetics, and pharmacodynamics.

Addex Pharmaceuticals has announced today that in a non-human primate model of Parkinson’s disease (PD) levodopa induced dyskinesia (LID), ADX48621 inhibited dose dependently both chorea and dystonia, the

France-based Servier has inaugurated a new manufacturing plant. The facility will also act as R&D center for the company. The facility will be based in Arklow, County Wicklow,

PURE Bioscience has entred into an agreement with Charlotte Products, whereby Charlotte Products will blend and package PURE’s patented silver dihydrogen citrate (SDC)-based hard surface disinfectant, which will

The Automation Partnership (TAP) has reported that its Advanced Projects Group has successfully collaborated with a major European antibody therapeutics company to deliver a custom automated protein purification

Boston Scientific has reported that it is planing to close the Florida’s stent manufacturing plant and is expected to move 1,400 jobs from the Miami area to Costa

Roche and the Department of Health of Junta de Andalucia, Spain, have signed an agreement for a co-operation in the Medical Genome Project (MGP). Its a research project